Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoterC Pramudji, S Shimura, S Ebara, et al.Cancer Research|June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cellsL Li, G Yang, S Ebara, et al.Nature Medicine|September 12, 1998
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cellsY Nasu, T L Timme, G Yang, et al.Cancer Research|May 19, 2001
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancerS A Tahir, G Yang, S Ebara, et al.Cancer Gene Therapy|March 17, 1999
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerS J Hall, S E Mutchnik, G Yang, et al.Molecular Endocrinology (Baltimore, Md.)|April 1, 1991
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progressionV W Merz, G J Miller, T Krebs, et al.Prostate Cancer and Prostatic Diseases|February 23, 2005
The emerging role of the PI3-K-Akt pathway in prostate cancer progressionL Li, M M Ittmann, G Ayala, et al.Expert Opinion on Biological Therapy|December 1, 2001
In situ gene therapy for prostate cancer: immunomodulatory approachesT C Thompson, T L Timme, S Ebara, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical studyR H Williams, A M Stapleton, G Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Association of p53 mutations with metastatic prostate cancerJ A Eastham, A M Stapleton, A E Gousse, et al.Pageof 11